Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer

• H. Rugo,
• J. O’Shaughnessy,
• C. Song,
• R. Broom,
• M. Gumus,
• T. Yamashita,
• B. San Antonio,
• A. Shahir,
• A. Zimmermann,
• F. Zagouri,
• M. Reinisch

Affiliations

H. Rugo

J. O’Shaughnessy

C. Song

R. Broom

M. Gumus

T. Yamashita

B. San Antonio

A. Shahir

A. Zimmermann

F. Zagouri

M. Reinisch